UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 ____________

                                   FORM 8-K

                               CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

            Date of Report (Date of earliest event reported)
                    November 8, 2007 (November 7, 2007)
                                 ____________

                      DIALYSIS CORPORATION OF AMERICA
          (Exact name of registrant as specified in its charter)

           Florida                        0-8527             59-1757642
(State or other jurisdiction           (Commission          (IRS Employer
       of incorporation)               File Number)       Identification No.)

1302 Concourse Drive, Suite 204, Linthicum, MD                 21090
   (Address of principal executive offices)                  (Zip Code)

     Registrant's telephone number, including area code: (410) 694-0500

                                Not Applicable
        (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))



Item 2.02 Results of Operations and Financial Condition.

     On November 7, 2007, Dialysis Corporation of America issued a press
release announcing its financial results for its third quarter ended
September 30, 2007.  A copy of the November 7, 2007 press release is attached
as an exhibit to this Current Report and is incorporated herein by reference.

     The information furnished pursuant to Item 2.02, including the Exhibit
(99)(i), shall not be deemed "filed" for purposes of Section 18 of the
Securities Exchange Act of 1934, nor shall it be deemed to be incorporated by
reference in any filing under the Securities Act of 1933.


Item 9.01 Financial Statements and Exhibits

     (d)  Exhibits

          (99)  Additional exhibits

                (i)  Press Release dated November 7, 2007.


                                   SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                       DIALYSIS CORPORATION OF AMERICA

                                          /s/ Stephen W. Everett
                                       By______________________________
                                          STEPHEN W. EVERETT
                                          President and Chief Executive
                                             Officer

Dated:  November 8, 2007



                                  EXHIBIT INDEX

 Exhibit
 Number
- ---------

   (99)     (i) Press Release dated November 7, 2007.